Aprecia Pharmaceuticals Email Formats

Pharmaceutical Manufacturing • 7200 Industrial Row Dr, Suite 200, United States • 51-100 Employees

Aprecia Pharmaceuticals Email Formats

Aprecia Pharmaceuticals uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@aprecia.com), used 75% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@aprecia.com	75%
{first name}.{last name}	john.doe@aprecia.com	20%
{first initial}	j@aprecia.com	5%

Key Contacts at Aprecia Pharmaceuticals

Christopher Lockwood

Senior Director, Product Development

Abby Daut

Director, Hr Services

Jacob Mayer

Director Of Engineering Innovation

Tyler Iverson

Director Of Operations

Mike Mayfield

Director, Quality Control / Analytical Development

Ted Kremer

Senior Director Of Operations

Aymsley Toomer

Director Marketing Projects

William C Burchett

Director Information Technologies

Bill Hall

Director Of Engineering

Company overview

Headquarters	7200 Industrial Row Dr, Suite 200, Mason, Ohio 45040, US
Phone number	+15139845000
Website	aprecia.com
NAICS	3254
SIC	283
Founded	2004
Employees	51-100
Socials

About Aprecia Pharmaceuticals

Aprecia offers commercial-scale production systems designed to accelerate clinical development and optimize commercial success. Our industry-leading 3DP formulation and manufacturing platforms transform drug development and delivery, meeting the unprecedented demand for complex and patient-friendly dosage forms. Aprecia joined with MIT Technology to build groundbreaking 3DP pharmaceutical technology with a mission towards advancing personalized medicine. With the first-of-its-kind innovations, Aprecia enables NDAs, extends product lifestyles, and accelerates clinical development. · Powder-based 3DP techniques use the widest set of ready materials compared to other additive manufacturing techniques. · The Binder Jetting technique provides the most flexibility when creating pharmaceutical formulations. · Aprecia is the first and only company in the world to obtain regulatory approval for a 3DP pharmaceutical product and utilized the MIT invented Binder Jetting technique to realize that feat. This transformed the use of 3DP from rapid prototyping in a laboratory setting to at scale production in a cGMP environment. Aprecia is a sister company of PRASCO The Leader In Authorized Generics and Trusted Pharmaceutical Partner Aprecia is poised to revolutionize pharmaceutical manufacturing through precision medicine and distributed manufacturing.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

Aprecia Pharmaceuticals has 31 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Aprecia Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-08-05	12	$30,000,000

Funding Insights

$30,000,000

Total funding amount

$30,000,000

Most recent funding amount

Number of funding rounds

Aprecia Pharmaceuticals Tech Stack

Discover the technologies and tools that power Aprecia Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Cloudflare Bot Management

Security

Gravity Forms

Form builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

EWWW Image Optimizer

Performance

MailChimp

Google Analytics

Analytics

Frequently asked questions

Aprecia Pharmaceuticals is located in 7200 Industrial Row Dr, Suite 200, US.

You can reach Aprecia Pharmaceuticals at +15139845000.

Aprecia Pharmaceuticals was founded in 2004, making it 22 years old. The company has established itself as a significant player in its industry over this time.

Aprecia Pharmaceuticals has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Aprecia Pharmaceuticals has raised a total of $30,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.